PrimeRFP SCOUT · Federal Contract Recompete Brief

75A50323F80027Leukine 250mcg VIL INJ (5pkg — Partner Therapeutics, Inc

Partner Therapeutics, Inc holds $147.4M across 9 federal awards, concentrated at Department of Health and Human Services (HHS). The prior award was single-bid — competitive dynamics may favor a challenge. Recompete timing centers on the Mar 29, 2027 PoP end — agencies typically plan 12–18 months ahead.

Aspr/Orm-Sns
Awarding office
Department of Health and Human Services (HHS)
Agency
Partner Therapeutics, Inc
Recipient
Mar 29, 2027
PoP end
$133.5M
Obligated
325412
NAICS
6515
PSC
1 bidders on last award

Watch this recompete

One email. No account. We ping you if the window moves.

Contract facts

Federal
Contract number75A50323F80027
Also listed as36F79723D0171-75A50323F80027
AgencyDepartment of Health and Human Services (HHS)
Awarding officeAspr/Orm-Sns
IncumbentPartner Therapeutics, Inc
UEIJ33MSDBJZMC6
NAICS325412

No full NAICS 325412 intel page yet. Browse NAICS intelligence

PSC6515
Parent IDIQ / IDV36F79723D0171
Place of performanceLEXINGTON, MA
Related solicitation75A50323Q00021
PoP end (current)Mar 29, 2027
PoP end (w/ options)Sep 29, 2027
Obligated$133.5M

LEUKINE 250MCG VIL INJ (5PKG) is a federal award for Department of Health and Human Services (HHS) held by Partner Therapeutics, Inc. Estimated value $133.5M ($133.5M obligated). Current period of performance ends Mar 29, 2027 (potential Sep 29, 2027). Last award drew 1 bidder. Place of performance: LEXINGTON, MA. Related solicitation 75A50323Q00021.

Recompete timing

Public
● Expiring in 180 days

Current PoP ends Mar 29, 2027 (180 days remaining). Agencies typically plan 12–18 months ahead — at 5.9 months out, that window is already open. The buying decision is likely already in motion.

Bonuses end Sept 30

Want the durability read on 75A50323F80027? One Pursuit Analysis, $500, inside 48 business hours.

  • 48 business hours
  • $500
  • Credits toward the Pack
Buy one Pursuit Analysis — $500

Incumbent footprint

Public record

Partner Therapeutics, Inc — $147.4M obligated across 9 awards (firm-wide, all agencies) · lead buyer Department of Health and Human Services (HHS).

% of firm-wide obligated ($147.4M) · all agencies
Department of Health and Human Services (HHS)$147.3M · 100%Department of Veterans Affairs (VA)$163K · 0%
Open full company profile →

Query this award live in SCOUT via MCP — personalized scoring, watchlists, and capture workflow across the corpus. Learn about SCOUT MCP →

More in SCOUT
Size up the competition →Research the incumbent →

Frequently asked questions

What is contract 75A50323F80027?

75A50323F80027 (Leukine 250mcg VIL INJ (5pkg) is a Aspr/Orm-Sns award with an estimated value of $133.5M, currently held by Partner Therapeutics, Inc. Figures are USASpending-sourced public-record facts plus SCOUT recompete analysis.

Which office awarded 75A50323F80027?

Aspr/Orm-Sns awarded 75A50323F80027 to Partner Therapeutics, Inc.

Who is the incumbent on 75A50323F80027?

Partner Therapeutics, Inc is the incumbent with $147.4M across 9 related awards in SCOUT’s public footprint. The current period of performance ends Mar 29, 2027.

When does Partner Therapeutics, Inc’s 75A50323F80027 come up for recompete?

SCOUT tracks a period-of-performance end of Mar 29, 2027. Actual solicitation timing can shift with extensions, bridges, or consolidations.

Want the durability read on 75A50323F80027? One Pursuit Analysis, $500, inside 48 business hours.

One Pursuit Analysis is $500 and credits toward the Sprint Pack. Delivery is 48 business hours. Start with the free Exposure Check if you want the list first.

Get the free Exposure Check

No card · under a minute · then the Sprint menu

Buy one Pursuit Analysis — $500

Credits toward the Sprint Pack

Compare plans

Data: Showing contracts ≥ $100K from federal procurement records (FPDS-NG, SAM.gov, and related repositories), normalized by PrimeRFP SCOUT. Each row keyed by Award ID (PIID); task orders appear as independent rows.

Data as of · refreshed monthlyLatest procurement action
Sources: USASpending, FPDS, SAM.gov · Public-record facts + SCOUT analysis shown above; personalized scoring in SCOUT.
primerfp.com/intel/contract/75A50323F80027